Search Results
The product title you are looking for is no longer available. Other similar products that may interest you are listed below:
|
Results for 'Commercial Insight: Antibacterials' |
|
|
| Title | Publication Date | Price | Relevance |
|---|---|---|---|
| Commercial Insight: Infectious Diseases Overview | Dec 2007 | £9,615 | 100% |
| Stakeholder Insight: Respiratory Tract Infections in the USA The demise of narrow-spectrum antibiotics |
Nov 2006 | £8,365 | 88% |
| Antibiotic Resistance and Antibiotic Technologies: Global Markets | Nov 2009 | £3,065 | 82% |
| Innovations in Combating Infectious Diseases Opportunities in Therapeutics and Diagnostics through Application of Proteomics, Genomics, Nanotechnology, and Novel Sources of Lead Generation |
Jun 2010 | £2,425 | 78% |
| Stakeholder Opinions: Biologics in Infectious Diseases Well Defined Target Populations Are Key to Commercial Success |
Mar 2008 | £2,400 | 68% |
| New Approaches to Pharma R&D: Evolving strategies to rejuvenate R&D efficiency | May 2009 | £3,605 | 66% |
| Pipeline Insight: Nosocomial Vaccines Minefield or Goldmine? |
Apr 2008 | £7,210 | 61% |
| DNA sequencing Technologies, Markets and Companies |
Jan 2012 | £1,815 | 56% |
| Trends in Pharmaceutical Portfolio Management Strategies to Maintain Profitability despite Adversity |
Sep 2008 | £2,405 | 56% |
| Global Ophthalmic Market Analysis & Forecasts to 2012 | Apr 2007 | £1,499 | 46% |
| The Indian Pharmaceutical Industry New strategies in a changing world |
Jan 2012 | £995 | 41% |
- Results 1 - 11 of 11
-
-
- 1
-
-
